FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940189035> ?p ?o ?g. }

• W2940189035 abstract "This workshop report summarizes the presentations, the breakout session outcomes, and the speaker panel discussions from the PDA Biosimilars Workshop held September 27-28, 2018, in Washington, DC. This format was deliberately selected for the workshop with the expectation of delivering a post-workshop paper on current best practices and existing challenges for sponsors. The event, co-chaired by Dr. Stephan Krause (AstraZeneca Biologics) and Dr. Emanuela Lacana (CDER/FDA), was attended by 140 agency and industry representatives. The workshop was separated into three major sessions P1: Regulatory Perspective, P2: Challenges in Biosimilar Development, and P3: Demonstrating Analytical Similarity. Each of the three sessions started with agency and industry presentations. Participants then split into two concurrent roundtable discussion groups to hear the answers to questions that had been provided to all participants one week prior to the event. The sessions were recorded. This paper provides consolidated answers to specific case studies for current challenges to sponsors and agencies. In addition, the panel discussion notes following each breakout roundtable session, as well as brief talk summaries of all speakers, are provided. The first session explored the challenges encountered with submission of biosimilar marketing applications from the perspectives of regulatory agencies. Expectations for a successful submission of the chemistry, manufacturing, and controls (CMC) information were described. The second session addressed high-level technical challenges and how to avoid pitfalls frequently encountered during biosimilar candidate development, including data quality expectations, creation of the final control strategy, and strategic choices necessary for candidate selection and development. Both regulatory perspectives and industry experience were shared. The last session explored the use of statistical tools to provide meaningful contributions to the demonstration of analytical similarity. The presentations highlighted common issues and practical challenges that arise during the application of statistical tools.LAY ABSTRACT: Significant challenges are still-remaining for sponsors and agencies to successfully develop and license Biosimilars. A Biosimilars Workshop was therefore held on 27-28 September 2018 in Washington, DC, to find practical solutions to the remaining challenges. The workshop planning committee with members from industry and agencies prepared specific case studies focused on some of most difficult situations. The workshop was separated into three major sessions (P1 - Regulatory Perspective; P2 - Challenges in Biosimilar Development; P3 - Demonstrating Analytical Similarity) and each session attempted to provide practical solutions to the relevant case studies. This first session explored the challenges encountered with submission of biosimilar marketing applications from the regulatory agencies' perspectives. Expectations for a successful submission of the CMC information were described. The second session addressed high-level technical challenges frequently encountered during biosimilar candidate development, including data quality expectations, the creation of the final control strategy, and strategic choices necessary for candidate selection and development. The last session explored the use of statistical tools to provide meaningful contributions to the demonstration of analytical similarity and practical challenges that arise during the application of statistical tools." @default.
• W2940189035 created "2019-04-25" @default.
• W2940189035 creator A5001253371 @default.
• W2940189035 creator A5003251463 @default.
• W2940189035 creator A5003408266 @default.
• W2940189035 creator A5014554796 @default.
• W2940189035 creator A5025949338 @default.
• W2940189035 creator A5026618493 @default.
• W2940189035 creator A5029973207 @default.
• W2940189035 creator A5032607185 @default.
• W2940189035 creator A5034970699 @default.
• W2940189035 creator A5035128174 @default.
• W2940189035 creator A5051340877 @default.
• W2940189035 creator A5058555394 @default.
• W2940189035 creator A5060744073 @default.
• W2940189035 creator A5073807304 @default.
• W2940189035 creator A5081015298 @default.
• W2940189035 creator A5083435037 @default.
• W2940189035 creator A5088350287 @default.
• W2940189035 date "2019-01-01" @default.
• W2940189035 modified "2023-10-18" @default.
• W2940189035 title "PDA Biosimilars Workshop Report (September 27—28, 2018)—Getting It Right the First Time for Biosimilar Marketing Applications" @default.
• W2940189035 doi "https://doi.org/10.5731/pdajpst.2019.010215" @default.
• W2940189035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31004040" @default.
• W2940189035 hasPublicationYear "2019" @default.
• W2940189035 type Work @default.
• W2940189035 sameAs 2940189035 @default.
• W2940189035 citedByCount "1" @default.
• W2940189035 countsByYear W29401890352020 @default.
• W2940189035 crossrefType "journal-article" @default.
• W2940189035 hasAuthorship W2940189035A5001253371 @default.
• W2940189035 hasAuthorship W2940189035A5003251463 @default.
• W2940189035 hasAuthorship W2940189035A5003408266 @default.
• W2940189035 hasAuthorship W2940189035A5014554796 @default.
• W2940189035 hasAuthorship W2940189035A5025949338 @default.
• W2940189035 hasAuthorship W2940189035A5026618493 @default.
• W2940189035 hasAuthorship W2940189035A5029973207 @default.
• W2940189035 hasAuthorship W2940189035A5032607185 @default.
• W2940189035 hasAuthorship W2940189035A5034970699 @default.
• W2940189035 hasAuthorship W2940189035A5035128174 @default.
• W2940189035 hasAuthorship W2940189035A5051340877 @default.
• W2940189035 hasAuthorship W2940189035A5058555394 @default.
• W2940189035 hasAuthorship W2940189035A5060744073 @default.
• W2940189035 hasAuthorship W2940189035A5073807304 @default.
• W2940189035 hasAuthorship W2940189035A5081015298 @default.
• W2940189035 hasAuthorship W2940189035A5083435037 @default.
• W2940189035 hasAuthorship W2940189035A5088350287 @default.
• W2940189035 hasConcept C108170787 @default.
• W2940189035 hasConcept C111472728 @default.
• W2940189035 hasConcept C112698675 @default.
• W2940189035 hasConcept C121332964 @default.
• W2940189035 hasConcept C126322002 @default.
• W2940189035 hasConcept C136764020 @default.
• W2940189035 hasConcept C138885662 @default.
• W2940189035 hasConcept C144024400 @default.
• W2940189035 hasConcept C144133560 @default.
• W2940189035 hasConcept C162853370 @default.
• W2940189035 hasConcept C2779182362 @default.
• W2940189035 hasConcept C2779530757 @default.
• W2940189035 hasConcept C2779662365 @default.
• W2940189035 hasConcept C2781433648 @default.
• W2940189035 hasConcept C36289849 @default.
• W2940189035 hasConcept C41008148 @default.
• W2940189035 hasConcept C509550671 @default.
• W2940189035 hasConcept C59491497 @default.
• W2940189035 hasConcept C62520636 @default.
• W2940189035 hasConcept C71924100 @default.
• W2940189035 hasConceptScore W2940189035C108170787 @default.
• W2940189035 hasConceptScore W2940189035C111472728 @default.
• W2940189035 hasConceptScore W2940189035C112698675 @default.
• W2940189035 hasConceptScore W2940189035C121332964 @default.
• W2940189035 hasConceptScore W2940189035C126322002 @default.
• W2940189035 hasConceptScore W2940189035C136764020 @default.
• W2940189035 hasConceptScore W2940189035C138885662 @default.
• W2940189035 hasConceptScore W2940189035C144024400 @default.
• W2940189035 hasConceptScore W2940189035C144133560 @default.
• W2940189035 hasConceptScore W2940189035C162853370 @default.
• W2940189035 hasConceptScore W2940189035C2779182362 @default.
• W2940189035 hasConceptScore W2940189035C2779530757 @default.
• W2940189035 hasConceptScore W2940189035C2779662365 @default.
• W2940189035 hasConceptScore W2940189035C2781433648 @default.
• W2940189035 hasConceptScore W2940189035C36289849 @default.
• W2940189035 hasConceptScore W2940189035C41008148 @default.
• W2940189035 hasConceptScore W2940189035C509550671 @default.
• W2940189035 hasConceptScore W2940189035C59491497 @default.
• W2940189035 hasConceptScore W2940189035C62520636 @default.
• W2940189035 hasConceptScore W2940189035C71924100 @default.
• W2940189035 hasLocation W29401890351 @default.
• W2940189035 hasLocation W29401890352 @default.
• W2940189035 hasOpenAccess W2940189035 @default.
• W2940189035 hasPrimaryLocation W29401890351 @default.
• W2940189035 hasRelatedWork W1987475070 @default.
• W2940189035 hasRelatedWork W1995439428 @default.
• W2940189035 hasRelatedWork W2014656120 @default.
• W2940189035 hasRelatedWork W2137145275 @default.
• W2940189035 hasRelatedWork W2348377848 @default.
• W2940189035 hasRelatedWork W2561630070 @default.
• W2940189035 hasRelatedWork W2748952813 @default.
• W2940189035 hasRelatedWork W2810230980 @default.
• W2940189035 hasRelatedWork W11036725 @default.

• next